Ryuji Kanno
Direktor/Vorstandsmitglied bei JEOL LTD.
Profil
Ryuji Kanno is currently an Outside Director at JEOL Ltd., a Director at Human Metabolome Technologies America, Inc., a Director at HMT Biomedical KK, and a Director at Human Metabolome Technologies Europe, B.V.
He was formerly the Chairman of Human Metabolome Technologies, Inc. from 2019 to 2020.
He also held non-executive director positions at Rigaku Corp.
and principal positions at HP, Inc. and Agilent Technologies Japan Ltd.
Kanno received his undergraduate degree from Tokyo University of Science in 1973.
Aktive Positionen von Ryuji Kanno
| Unternehmen | Position | Beginn |
|---|---|---|
| JEOL LTD. | Direktor/Vorstandsmitglied | 25.06.2021 |
Human Metabolome Technologies America, Inc.
 Human Metabolome Technologies America, Inc. Medical/Nursing ServicesHealth Services Part of Human Metabolome Technologies, Inc., Human Metabolome Technologies America, Inc. develops diagnostic technology and medical products. The private company is based in Boston, MA. | Direktor/Vorstandsmitglied | 01.10.2012 |
HMT Biomedical KK
 HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Direktor/Vorstandsmitglied | 01.01.2016 |
| Human Metabolome Technologies Europe, B.V | Direktor/Vorstandsmitglied | 01.05.2017 |
Ehemalige bekannte Positionen von Ryuji Kanno
| Unternehmen | Position | Ende |
|---|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Präsident | 21.09.2019 |
Rigaku Corp.
 Rigaku Corp. Medical SpecialtiesHealth Technology Rigaku Corp. designs and manufactures scientific instruments. Its products include X-ray diffraction instruments, X-ray fluorescence , small angle X-ray scattering , protein crystallography, handheld laser induced breakdown spectrometers, process elemental analyzers, thermal analysis , non-destructive testing, small molecule crystallography, stress analyzers, X-ray imaging, evolved gas analysis, and conductor metrology. The company was founded in 1951 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | - |
| Agilent Technologies Japan Ltd. | Corporate Officer/Principal | - |
| HP INC. | Corporate Officer/Principal | - |
Ausbildung von Ryuji Kanno
| Tokyo University of Science | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Health Technology |
| HP INC. | Electronic Technology |
| JEOL LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Agilent Technologies Japan Ltd. | |
Human Metabolome Technologies America, Inc.
Human Metabolome Technologies America, Inc. Medical/Nursing ServicesHealth Services Part of Human Metabolome Technologies, Inc., Human Metabolome Technologies America, Inc. develops diagnostic technology and medical products. The private company is based in Boston, MA. | Health Services |
HMT Biomedical KK
HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Health Technology |
Rigaku Corp.
Rigaku Corp. Medical SpecialtiesHealth Technology Rigaku Corp. designs and manufactures scientific instruments. Its products include X-ray diffraction instruments, X-ray fluorescence , small angle X-ray scattering , protein crystallography, handheld laser induced breakdown spectrometers, process elemental analyzers, thermal analysis , non-destructive testing, small molecule crystallography, stress analyzers, X-ray imaging, evolved gas analysis, and conductor metrology. The company was founded in 1951 and is headquartered in Tokyo, Japan. | Health Technology |
| Human Metabolome Technologies Europe, B.V |
